ethyldimethylaminopropyl carbodiimide has been researched along with epidermal growth factor in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Honegger, AM; Schlessinger, J; Schmidt, A; Ullrich, A | 1 |
Borrello, I; Chambaz, EM; Cochet, C; Kashles, O; King, CR; Schlessinger, J | 1 |
2 other study(ies) available for ethyldimethylaminopropyl carbodiimide and epidermal growth factor
Article | Year |
---|---|
Separate endocytic pathways of kinase-defective and -active EGF receptor mutants expressed in same cells.
Topics: Animals; Clone Cells; Cross-Linking Reagents; Down-Regulation; Endocytosis; Epidermal Growth Factor; ErbB Receptors; Ethyldimethylaminopropyl Carbodiimide; Half-Life; Iodine Radioisotopes; Kinetics; Ligands; Mutation; Protein-Tyrosine Kinases; Transfection | 1990 |
Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent.
Topics: Carbodiimides; Carcinoma, Squamous Cell; Chromatography, Affinity; Cross-Linking Reagents; Electrophoresis, Polyacrylamide Gel; Epidermal Growth Factor; ErbB Receptors; Ethyldimethylaminopropyl Carbodiimide; Humans; Immunoassay; Kinetics; Macromolecular Substances; Molecular Weight; Phosphorylation; Tumor Cells, Cultured | 1988 |